A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 5, 1997, Pages 1030-1038

  Lovett, S M ^a   Weiss, J D ^a   Diogo, M J ^a   Williams, P T ^a   Garite, T J ^a  

^a East Bay Perinatal Medical Associates   (United States)

Author keywords

antenatal corticosteroid therapy; penicillin and pregnancy; Preterm premature rupture membranes

Indexed keywords

AMPICILLIN; SULBACTAM; SULTAMICILLIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BIRTH WEIGHT; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NEWBORN MORTALITY; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TREATMENT PLANNING;

EID: 0031009480     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70398-3     Document Type: Article

References (25)

1. RS Gibbs JD. Blanco Premature rupture of the membranes Obstet Gynecol 60 1982 671 679
2. J Taylor TJ. Garite Premature rupture of membranes before fetal viability Obstet Gynecol 64 1984 615 620
3. H McDonald R Vigneswaran JA. O'Loughlin Group B streptococcal colonization and preterm labor Aust N Z Obstet Gynaecol 29 1989 291 293
4. LS Alger JC Lovchik JR Hebel LR Blackmon MC. Crenshaw The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome Am J Obstet Gynecol 159 1988 397 404
5. H Minkoff AN Grunebaum RH Schwarz J Feldman M Cummings W Cromblehome Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy Am J Obstet Gynecol 150 1984 965 972
6. JA McGregor JI French D Lawellin A Franco-Buff C Smith JK. Todd Bacterial protease induced reduction of chorioamniotic membrane strength and elasticity Obstet Gynecol 69 1987 167 174
7. JA McGregor JN Schoonmaker BD Lunt DW. Lawellin Antibiotic inhibition of bacterial induced fetal membrane weakening Obstet Gynecol 76 1990 124 128
8. RL Naeye EC. Petors Causes and consequences of premature rupture of fetal membranes Lancet 1 1980 192 194
9. National Institutes of Health Consensus Development Panel Effect of corticosteroids for fetal maturation on perinatal outcomes JAMA 273 1995 413 417
10. WJ Morales JL Angles WF O'Brien RA. Knuppel Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study Obstet Gynecol 73 1989 721 726
11. E Amon SV Lewis BM Sibai MA Villar KL. Arheart Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study Am J Obstet Gynecol 159 1988 539 543
12. MM Johnston L Sanchez-Ramos AJ Vaughn MW Todd GI. Benrubi Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective double-blind trial Am J Obstet Gynecol 163 1990 743 747
13. GL. Maxwell Preterm premature rupture of membranes Obstet Gynecol Surv 48 1993 576 583
14. JA McGregor JI French K. Seo Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective double-blind placebo-controlled trial of erythromycin Am J Obstet Gynecol 165 1991 632 640
15. JA McGregor JI French K. Seo Adjunctive clindamycin therapy for preterm labor: results of a double-blind placebo-controlled trial Am J Obstet Gynecol 165 1991 867 875
16. JT Christmas SM Cox W Andrews J Dax KJ Leveno LC. Gilstrap Expectant management of preterm ruptured membranes: effects of antimicrobal therapy Obstet Gynecol 80 1992 759 762
17. BM Mercer ML Moretti RR Prevost BM. Sibai Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients Am J Obstet Gynecol 166 1992 794 802
18. SJ Fortunato SI Welt M Eggleston J Cole EC Bryant MG. Dodson Prolongation of the latency period in preterm premature rupture of the membranes using prophylactic antibiotics and tocolysis J Perinatol 10 1990 252 256
19. RT Greenberg GD. Hankins Antibiotic therapy in preterm premature rupture of membranes Clin Obstet Gynecol 34 1991 742 750
20. A. Ohlsson Treatment of preterm premature rupture of the membranes: a meta-analysis Am J Obstet Gynecol 160 1989 890 906
21. SL Hillier J Martius M Krohn N Kiviat KK Holmes DA Eschenbach A case-control study of chorioamniotic infection and histologic chorioamnionitis in prematurity N Engl J Med 319 1988 972 978
22. TR. Moore Assessment of amniotic fluid volume in at-risk pregnancies Clin Obstet Gynecol 38 1995 78 90
23. FG Cunningham PC MacDonald KJ Leveno NF Gant LC. Gilstrap Williams' obstetrics 19th edition 1993 Appleton & Lange Norwalk (CT)
24. DF Lewis MT Fontenot GG Brooks R Wise MB Perkins AR. Heymann Latency period after preterm premature rupture of membranes: a comparison of ampicillin with and without sulbactam Obstet Gynecol 86 1995 392 395
25. JL. Fleiss The statistical basis of meta-analysis Stat Methods Med Res 2 1993 121 145